Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate".
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25634839.
- Also identified by DOI 10.1016/j.jacc.2014.10.059.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atherosclerotic cardiovascular disease (ASCVD) continues to increase annually in the United States along with its associated enormous costs. A multidisciplinary cardiac rehabilitation (CR) and risk reduction program is an essential component of ASCVD prevention and management. Despite the strong evidence for CR in the secondary prevention of ASCVD, it remains vastly underutilized due to significant barriers. The current model of CR delivery is unsustainable and needs significant improvement to provide cost-effective, patient-centered, comprehensive secondary ASCVD prevention.
Medical subject headings
- Atherosclerosis
- Coronary Artery Disease